Search results
Jump to navigation
Jump to search
- {{r|Platelet}}195 bytes (22 words) - 15:14, 30 June 2009
- {{r|Platelet}}178 bytes (19 words) - 21:09, 10 December 2009
- {{r|Platelet activation}}151 bytes (16 words) - 17:22, 27 August 2008
- In [[pharmacology]], '''prasugrel''' is a [[platelet aggregation inhibitor]] of the [[thienopyridine]] class that blocks [[adeno406 bytes (38 words) - 17:36, 13 July 2011
- {{r|Platelet}}362 bytes (44 words) - 11:50, 15 February 2009
- ...' include [[eptifibatide]] and [[tirofiban]]. These medication block the [[platelet glycoprotein GPIIb-IIIa complex]] and are used for treating [[acute coronar671 bytes (85 words) - 10:09, 17 October 2010
- {{r|Platelet||**}}556 bytes (65 words) - 22:32, 2 June 2010
- ...d concentration, reduces incidence of cardiovascular disorders, prevents [[platelet aggregation]], and inhibits [[arachidonic acid]] conversion into the [[thro540 bytes (63 words) - 03:15, 7 October 2013
- {{r|Platelet glycoprotein GPIIb-IIIa complex}}469 bytes (58 words) - 16:53, 11 January 2010
- {{r|Platelet}}618 bytes (73 words) - 13:59, 26 November 2010
- ...nal |author=Fritz E, Ludwig H, Scheithauer W, Sinzinger H |title=Shortened platelet half-life in multiple myeloma |journal=Blood |volume=68 |issue=2 |pages=514 ...s Disease. The chronic form in adults is usually caused by antibodies to [[Platelet glycoprotein GPIIb-IIIa complex]] or Ib-IX.<ref name="isbn0-7216-0187-1"/>4 KB (579 words) - 13:26, 23 November 2010
- .../> This leaves vasoconstriction, platelet aggregation, and thrombosis from platelet thromboxane A2 mediated by COX-1 intact.<ref name="pmid-16968830"/>2 KB (265 words) - 09:16, 28 December 2010
- {{r|Platelet}}588 bytes (71 words) - 16:58, 11 January 2010
- {{r|Platelet}}619 bytes (80 words) - 21:25, 11 January 2010
- {{r|Platelet}}610 bytes (73 words) - 15:48, 11 January 2010
- {{r|Platelet}}651 bytes (80 words) - 10:59, 11 January 2010
- {{r|Platelet}}679 bytes (85 words) - 15:36, 11 January 2010
- ...actor complex. The von Willebrand factor has receptors for [[collagen]], [[platelet]]s, and [[ristocetin]] activity as well as the immunologically distinct ant629 bytes (86 words) - 17:31, 10 July 2010
- {{r|Platelet}}834 bytes (105 words) - 19:56, 11 January 2010
- {{r|Platelet}}759 bytes (101 words) - 15:55, 11 January 2010